Human growth hormone (HGH) affects bodybuilders through several distinct pathways: it accelerates fat loss, strengthens connective tissue, and works alongside other hormones to support muscle growth. Its actual role in building muscle is more nuanced than most people assume, and understanding what HGH does well versus what it doesn’t helps explain why bodybuilders use it the way they do.
How HGH Drives Fat Loss
Fat burning is the most direct and well-documented effect of HGH for bodybuilders. Growth hormone activates an enzyme called hormone-sensitive lipase in fat cells, which breaks stored fat into free fatty acids that your body can use for energy. At the same time, HGH suppresses lipoprotein lipase, the enzyme responsible for pulling fat from the bloodstream into fat cells for storage. The net effect is that fat gets broken down faster and stored more slowly.
HGH also strips away the protective coating around fat droplets inside cells. It does this by downregulating a protein that normally shields stored fat from being mobilized. This is why bodybuilders often describe HGH as giving them a “tighter” or “drier” look, particularly in the midsection. The visible leanness that comes with HGH use is largely a fat-loss effect rather than a muscle-building one.
The Muscle Growth Question
HGH’s reputation as a muscle builder is partly deserved and partly overstated. Growth hormone itself doesn’t directly stimulate the contractile fibers inside your muscles, the ones that generate force and size. A study in healthy young adults given HGH for 14 days found significant increases in collagen production within muscle tissue but no change in the rate of myofibrillar protein synthesis, the actual process that builds the muscle fibers you train.
What HGH does is trigger the liver and local tissues to produce IGF-1, a secondary hormone that activates one of the most important signaling chains for muscle growth. IGF-1 switches on the cell’s protein-building machinery, increasing the rate at which amino acids get assembled into new muscle protein. Simultaneously, IGF-1 dials down the enzymes responsible for breaking muscle protein apart. It also activates satellite cells, the stem cells that sit on the surface of muscle fibers and donate their nuclei during repair and growth. More nuclei per fiber means a greater capacity for that fiber to expand.
There’s a persistent idea that HGH causes hyperplasia, the creation of entirely new muscle fibers rather than just enlarging existing ones. The scientific consensus does not support this in humans. Increases in muscle size come from making existing fibers larger, not from growing new ones. Fiber splitting has been observed in animal models under extreme stretch, but it has not been documented in people.
Connective Tissue and Recovery
Where HGH stands out most clearly is in strengthening tendons, ligaments, and the connective tissue matrix within muscles. In a placebo-controlled study, just 14 days of HGH administration increased collagen gene expression in tendons by nearly four-fold and boosted tendon collagen protein production by 1.3-fold. In muscle tissue, collagen gene expression more than doubled, and collagen protein synthesis showed a trend toward a nearly six-fold increase.
For bodybuilders, this matters in practical ways. Heavy training places enormous stress on joints and connective tissue, and injuries to tendons and ligaments are common when muscle strength outpaces the structural support around it. HGH helps close that gap. A large clinical trial of over 400 patients found that high-dose growth hormone treatment shortened healing time for closed fractures. Bodybuilders frequently report that HGH allows them to train harder with fewer joint-related setbacks, and the collagen data supports that experience.
Why Bodybuilders Stack HGH With Other Compounds
HGH is rarely used alone in competitive bodybuilding. It’s typically combined with anabolic steroids and sometimes insulin because these three substances interact in ways that amplify each other’s effects. Surveys of male bodybuilders found that about 21% admitted to using anabolic steroids, and roughly 7% of those also used insulin concurrently. The combination of all three is common at the upper levels of the sport.
The logic behind the stack: anabolic steroids directly stimulate muscle protein synthesis and nitrogen retention. HGH mobilizes fat and elevates IGF-1. Insulin drives nutrients, particularly glucose and amino acids, into muscle cells. Together, the idea is to build muscle (steroids), fuel the process (insulin), and stay lean while strengthening the structural framework (HGH). Resistance training itself also triggers natural spikes in growth hormone and IGF-1, so exogenous HGH is layered on top of a system already primed by exercise.
Insulin Resistance and Blood Sugar
The most clinically significant side effect of HGH use is insulin resistance. The same fat-burning mechanism that makes HGH appealing also floods the bloodstream with free fatty acids. Those fatty acids interfere with insulin signaling in muscle and liver cells through a cascade that involves lipid byproducts blocking the normal insulin response. Growth hormone also directly disrupts insulin signaling by increasing certain regulatory proteins that suppress insulin’s ability to function.
In clinical studies, fasting blood sugar and insulin levels typically rise within the first six months of HGH treatment. In patients with legitimate growth hormone deficiency using therapeutic doses, these levels often normalize after one to two years. But bodybuilders frequently use doses several times higher than therapeutic levels, and the combination with exogenous insulin creates a particularly volatile metabolic environment. The irony is that bodybuilders sometimes add insulin specifically to counteract HGH-induced insulin resistance, which introduces its own serious risks including dangerous drops in blood sugar.
Physical Side Effects of Long-Term Use
Chronic exposure to elevated growth hormone levels produces changes associated with acromegaly, a condition normally caused by a pituitary tumor. In adults, excess HGH causes bones, cartilage, and organs to enlarge. The hands and feet swell, often requiring larger shoe sizes. The brow and jaw protrude, the nose and ears grow, the tongue thickens, and spacing between teeth increases. Skin becomes thicker, oilier, and more prone to sweating and odor. The voice deepens. Skin tags may appear or darken.
Internal organ growth is a serious concern. The heart, liver, and intestines can all enlarge with prolonged HGH excess. The distended midsections seen on some professional bodybuilders, often called “HGH gut” or “palumboism,” are widely attributed to organ growth and fluid retention driven by high-dose growth hormone and insulin use. Joint pain, headaches, and vision problems are also common with sustained supraphysiological levels.
Natural HGH Patterns and Sleep
Your body produces growth hormone in pulses throughout the day, with the two strongest natural triggers being sleep and exercise. The largest GH pulse occurs shortly after you fall asleep and continues rising during the first four hours of the night. Nearly all of this release happens during deep slow-wave sleep, with very little secreted during lighter REM phases. Peak secretory bursts typically occur between 11 p.m. and 2:30 a.m.
Disrupted sleep patterns scatter GH release into smaller, unpredictable pulses spread across waking hours, reducing the concentrated anabolic window that deep sleep provides. This is one reason sleep quality has such a measurable impact on body composition and recovery. Bodybuilders using exogenous HGH bypass this natural rhythm entirely, but for anyone relying on their own production, consistent deep sleep is the single most powerful lever.
Detection in Drug Testing
HGH has historically been difficult to detect because exogenous growth hormone is structurally identical to what your pituitary gland produces. Current anti-doping tests use an isoform approach: your body naturally releases a mix of different GH variants, while pharmaceutical HGH contains only one. After a single injection, tests can identify exogenous HGH with 86% sensitivity within 12 hours, but no positives are detected beyond that window. Even with repeated dosing, detection drops to about 6% at the 24-hour mark. This narrow detection window is a major reason HGH remains widely used in tested sports despite being banned by virtually every athletic organization.

